Page 1691 - Clinical Small Animal Internal Medicine

Index 1629

PRAA see persistent right aortic arch history and clinical signs 1161 PTCE see percutaneous thrombogenic
VetBooks.ir precipitation‐crystallization protein catabolism 650 PTE see pulmonary thromboembolism
prognosis 1162–1163
coil embolization
prebiotics 623–624
treatment 1162, 1162
theory 1123
PTEN see primitive neuroectodermal
precision 8 protein‐losing enteropathy (PLE) tumors
precordial thump 204 627, 630, 632–633, 636–637 PTH see parathyroid hormone
preload 176 protein‐losing nephropathy PTH‐rp see parathyroid hormone‐
prepuce 1313–1314 (PLN) 627, 942–943 related peptide
pressure support ventilation (PSV) 395 protein/polypeptide hormones 29 ptosis 827, 827
prevalence 12–13, 18 proteinuria public health
preventive nursing care 454–455 chronic kidney disease 1165, 1166, actinomycosis 979
primary focal neoplasia 667, 667 1168–1170, 1169 anthrax 974
primary hyperparathyroidism glomerular disease 1102–1103 bartonellosis 924
(PHPTH) 1082 polyuria and polydipsia 66 botulism 970
primary visceral mastocytosis 1359 proton pump inhibitors (PPI) canine brucellosis 965
primitive neuroectodermal tumors esophageal disorders 560–561 canine distemper virus 853
(PTEN) 779 exocrine pancreatic canine herpesvirus 856
PRL see prolactin insufficiency 589 canine infectious respiratory disease
probiotics 623–626, 637 gastritis and gastric complex 1037–1038
proctoscopy 616 ulceration 553 canine influenza virus 867
proinflammatory cytokines pancreatitis 599 canine parvovirus type 2 859
445–446 protoscopy 523–524 coccidia 1025, 1026
prokinetics 574, 575, 579–580, 612 protozoal and protozoa‐like Ebola virus 902
prolactin (PRL) 38, 41 infections 1003–1021 ehrlichiosis and anaplasmosis
prolapse 617–618, 617 cutaneous manifestations of systemic 911–912
proliferation markers 51 disease 1485, 1486 feline coronavirus 875
proliferative signaling 1209 forebrain disorders 783–784 feline immunodeficiency
proopiomelanocortin (POMC) laboratory diagnosis 839–843 virus 885
38–39, 52 see also individual agents/diseases feline leukemia virus 881
propagating epidemic curves PRR see pattern recognition receptors feline parvovirus 870
835, 835 PRT see palliative radiation therapy feline viral upper respiratory tract
prophylactic antimicrobial pruritus disease 889
protocols 1194 allergic skin diseases 1416–1417 fungal infections 987–990, 992,
prosenchephalon see forebrain alopecia 1437–1438 994–995, 997–1000
disorders approach to the dermatologic hemotropic Mycoplasma 929
prostacyclins 225 patient 1376 infectious disease 833–834, 836
prostate tumors 502, 503, atopic dermatitis 1403–1412 kennels and multicat
1312–1313 bacterial pyodermas 1466 environments 1065
prostatic cysts 1157–1160 parasitic skin diseases 1450, leptospirosis 948–949
prostatic diseases 1157–1163 1453–1454, 1457 Lyme borreliosis 944
anatomy and physiology PS see pulmonary valve stenosis mycobacteriosis 983–984
1157, 1158 pseudocoprostasis 614–615 nocardiosis 980
benign prostatic hyperplasia and pseudohyperparathyroidism 1522 nonhemotropic Mycoplasma,
prostatic cysts 1157–1160, 1159, Pseudomonas spp. Ureaplasma, and L‐form
1160 bacterial pyodermas 1465, 1465 bacteria 934
paraprostatic cysts nocosomial and multidrug‐resistant One Health 3–5
1160–1161, 1161 infections 1060 papillomaviruses 863
prostatitis and prostatic abscesses otitis externa 1472 Q fever 960
1161–1163, 1162, 1162 PSTI see pancreatic secretory trypsin rabies 891, 895–897
squamous metaplasia of prostatic inhibitor salmon poisoning disease 914
epithelial cells 1163 PSV see pressure support ventilation surgical, traumatic, and bite wound
prostatitis 1161–1163 PSVA see portosystemic vascular infections 1032, 1034
diagnosis 1161–1162, 1162 anomalies tetanus 968
etiology 1161 psychological etiologies 1574 tularemia 957